product summary
request information :
company name :
EMD Millipore
other brands :
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type :
product name :
Milli-Mark™ Anti-SSEA3 Alexa 488 Antibody, clone MC-631
catalog :
quantity :
100 tests
clonality :
host :
application :
flow cytometry
more info or order :
product information
Catalog Number :
Subcategory :
Stem Cell Research
Product Name :
Milli-Mark™ Anti-SSEA3 Alexa 488 Antibody, clone MC-631
Product Type :
Clonality :
Monoclonal Antibody
Host Name :
Antigen :
SSEA3 Alexa 488
Conjugate :
Isotype :
Product Description :
Milli-Mark™ Anti-SSEA3 Alexa 488 Antibody, clone MC-631
Cross Reactivity :
Background :
The cell-surface markers used routinely to identify undifferentiated human embryonic stem cells (hESCs) were initially characterized as markers for mESCs, mouse embryonic carcinomas (ECs), or human EC cells. Stage-specific embryonic antigen-3 (SSEA-3) and SSEA-4 are widely used as cell-surface markers to define both human and mouse ESCs. SSEA-3 and SSEA-4 are expressed on undifferentiated hESCs but not on undifferentiated mESCs.
Immunogen :
4-8 cell stage mouse embryos
Specificity :
Reacts with the Stage-specific embryonic antigen-3 (SSEA-3) that is expressed upon the surface of human teratocarcinoma stem cells (EC), human embryonic germ cells (EG) and human embryonic stem cells (ES).
Package Size :
100 tests
Uses :
Flow Cytometry
Storage :
Maintain refrigerated at 2-8 °C protected from light in undiluted aliquots for up to 6 months from date of receipt.
more info or order :
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany

Hundreds of New Antibodies in the areas of:
  • • Cancer
  • • Nuclear Signaling
  • • Apoptosis
  • • Cardiovascular Disease
  • • Developmental Biology
  • • Metabolic Disease
  • • Neurodegenerative Disease
  • • Cell Biology
View all the new antibodies at